Summary
Fast growing biotech company IDS has signed a deal with a US conglomerate which will increase its pounds 4m sales by up to 50pc within months.
IDS, or Immunodiagnostic Systems, has grown into a business with 50 staff and opened a US branch last summer.See the full content of this document
Extract
On Road to Rapid Growth
The South Tyneside company is one of just two in the UK to have featured in the last six consecutive Del...
See the full content of this document
Sponsored links
